- JP-listed companies
- Daito Pharmaceutical Co., Ltd.
- Balance sheet
Daito Pharmaceutical Co., Ltd.【JP:4577】Balance sheet
Market cap
¥41B
P/E ratio
17.8x
| 2014/05 | 2015/05 | 2016/05 | 2017/05 | 2018/05 | 2019/05 | 2020/05 | 2021/05 | 2022/05 | 2023/05 | 2024/05 | 2025/05 | |
| Cash and cash equivalents | - | 1,919 | 1,351 | 1,617 | 1,711 | 1,819 | 3,084 | 3,373 | 4,381 | 3,607 | 2,727 | 2,207 |
| Accounts receivable, net | - | 9,865 | 8,813 | 9,389 | 8,831 | 9,395 | 9,066 | 8,382 | - | - | - | - |
| Inventories | - | 836 | 1,315 | 1,692 | 2,906 | 2,780 | 3,483 | 4,249 | 4,875 | 5,626 | 7,877 | 6,843 |
| Total current assets | - | 21,717 | 22,081 | 24,346 | 25,056 | 24,361 | 30,855 | 32,430 | 37,909 | 40,663 | 41,460 | 41,708 |
| Property, plant and equipment, net | - | 16,441 | 17,447 | 17,878 | 18,654 | 18,732 | 19,400 | 21,372 | 23,116 | 25,837 | 31,972 | 31,826 |
| Marketable securities, non-current | - | 3,358 | 3,088 | 2,829 | 2,877 | 2,780 | 3,144 | 2,802 | 2,752 | 2,964 | 3,188 | 2,091 |
| Total non-current assets | - | 20,588 | 21,259 | 21,362 | 22,140 | 22,389 | 23,395 | 25,309 | 27,030 | 29,888 | 36,247 | 36,296 |
| Total assets | - | 42,305 | 43,340 | 45,708 | 47,196 | 46,749 | 54,250 | 57,739 | 64,939 | 70,552 | 77,708 | 78,004 |
| Accounts payable | - | 4,177 | 3,644 | 3,587 | 3,621 | 4,086 | 4,330 | 4,360 | 4,493 | 4,435 | 5,262 | 4,681 |
| Short-term debt | - | 3,050 | 4,170 | 2,750 | 1,400 | - | - | - | - | - | - | - |
| Long-term debt, current | - | 2,472 | 2,114 | 2,055 | 1,965 | 1,852 | 1,512 | 1,362 | 1,189 | 1,429 | 2,099 | 3,099 |
| Total current liabilities | - | 15,986 | 15,066 | 15,235 | 13,684 | 11,618 | 15,054 | 12,859 | 14,069 | 15,428 | 18,505 | 17,049 |
| Long-term debt, non-current | - | 3,435 | 3,671 | 3,694 | 4,019 | 3,094 | 1,581 | 2,018 | 2,247 | 3,368 | 4,669 | 6,569 |
| Total non-current liabilities | - | 4,465 | 4,714 | 4,659 | 5,017 | 3,782 | 2,327 | 2,963 | 3,196 | 4,151 | 6,937 | 8,887 |
| Total liabilities | - | 20,451 | 19,780 | 19,894 | 18,701 | 15,400 | 17,381 | 15,822 | 17,265 | 19,580 | 25,443 | 25,936 |
| Common stock and paid-in capital | - | 8,622 | 8,622 | 8,622 | 8,622 | 8,622 | 10,627 | 12,428 | 13,948 | 14,258 | 14,258 | 14,258 |
| Retained earnings | - | 11,138 | 13,329 | 15,610 | 18,239 | 21,302 | 24,743 | 28,332 | 32,338 | 35,006 | 37,087 | 37,179 |
| Stockholders' equity | 16,625 | 21,855 | 23,560 | 25,814 | 28,496 | 31,349 | 36,868 | 41,917 | 47,674 | 50,971 | 52,265 | 52,067 |